Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Deborah Christen(Düsseldorf University Hospital), Andreas Burchert(Philipps University of Marburg), Stephan Metzelder(Philipps University of Marburg), Andreas Klameth(Philipps University of Marburg), Alexander Burchardt(Johannes Gutenberg University Mainz), Elisabeth Mack(Universitätsklinikum Gießen und Marburg), Cornelia Brendel(Philipps University of Marburg), Andreas Neubauer(RWTH Aachen University), Heinz‐Gert Hoeffkes(Klinikum Fulda), Christian Wilhelm(Philipps University of Marburg), Kristina Sohlbach(Philipps University of Marburg), Ellen Wollmer(Philipps University of Marburg), Mathias Rummel(Universitätsklinikum Gießen und Marburg), Philippe Kostrewa(Universitätsklinikum Gießen und Marburg), Thomas Wündisch, Marius Dohse(Center for Cancer Research), Corinna Trenker(Universitätsklinikum Gießen und Marburg), Ralph Naumann(University of Siegen), Christoph Mann(Universitätsklinikum Gießen und Marburg)
Cited by 3
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573